Jennifer Barrett, Assistant Editor

A particularly dangerous synthetic substance – fentanyl – is increasingly making its way into illicit street drugs and causing drug overdose deaths to skyrocket.

Have scientists found a new drug that could curb alcohol cravings and treat addiction?

The FDA has approved Allergan’s supplemental new drug application to update the label for their complicated urinary tract infection (cUTI) treatment.

President Donald Trump signed an executive order this week that could have direct implications for the FDA.

Quadracel is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis.

Adults who have HIV are more likely to develop diabetes than the general population, a study published in BMJ Open Diabetes Research & Care estimates.

Officials from Sanofi Pasteur, the vaccine division of Sanofi, announced the availability of their new pediatric vaccine formulation in the United States.

President Donald Trump signed an executive order this week that could have direct implications for the FDA.

The operator of an illegal online pharmacy that distributed narcotics and other prescription medication was sentenced to 8 years in prison.

The FDA has approved Teva’s newest asthma treatment for adolescent and adult patients.

Antimicrobial-resistant infections have become an alarming threat to public health. Drug-resistant tuberculosis (TB) is a particularly widespread issue that can be especially damaging or fatal.

Elevated levels of belladonna could pose a risk to infants and children.

Excessive amounts of the toxic substance belladonna have been found in certain homeopathic teething tablets, FDA officials confirmed in an announcement.

In Massachusetts, unique occurrences of sudden, onset amnesia and acute, complete, and bilateral ischemia of the hippocampus were identified in a number of individuals.

A recently-published Institute for Safe Medication Practices (ISMP) report details updated concerns about newer drugs used to treat hepatitis C virus (HCV).

The FDA has approved Ironwood and Allergan’s Linzess (linaclotide) for an additional dosing of 72 mcg.

Pharmacists continue to rank big in lists that highlight the profession’s value.

Using bezlotoxumab lowers the rate of recurrent Clostridium difficile infection more than a placebo alone, according to results of 2 phase 3 trials published this week in the New England Journal of Medicine.

Researchers have found a way to potentially combat the damaging effects of neurodegenerative diseases such as Alzheimer’s.

Naloxone nasal spray will be available as a 2-mg formulation for the emergency treatment of opioid overdoses.

A new study highlights important changes in trends and patterns among cancer mortality in the United States.

A confirmed customer report of the presence of particulate matter within a single vial prompted Hospira to recall the injectable antibiotic, FDA officials announced.

Officials with Adapt Pharma announced the FDA approval of Narcan (naloxone HCI) Nasal Spray additional dosing.

Seven individuals were arrested and indicted for their involvement in a prescription forgery scheme aimed at illicitly obtaining narcotics for resale.

Pharmacists continue to rank big in lists that highlight the profession’s value.

Poisonous mushrooms may hold the key to more efficiently treating diseases, findings from a recent study report.

A new study, published in Psychiatric Services, reveals a missed opportunity for early HIV detection and treatment.

Three people have been arrested for attempting to fill fraudulent prescriptions, thanks to a local pharmacist’s tip to law enforcement.

A new trivalent vaccine that has proven effective in the prevention of HSV-2 in animal trials could be headed for human trials soon.

Researchers in England set out to determine whether the risk of diabetes development was present at the onset of schizophrenia, as opposed to after a period of time with the illness.